Evidence map›Paper›PMID 18245081›Full record

ArticleThe Journal of biological chemistry2008

Dissociation from the oligomeric state is the rate-limiting step in fibril formation by kappa-casein.

Heath Ecroyd, Tomas Koudelka, David C Thorn, Danielle M Williams, Glyn Devlin, Peter Hoffmann, John A Carver

Open access · hybridAbstract read
In one paragraph

Article in The Journal of biological chemistry, 2008. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
9.4field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 83 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. The multifaceted nature of αB-crystallin.Cell stress & chaperones · 2020
    Review
  6. Article
  7. The structured core domain of αB-crystallin can prevent amyloid fibrillation and associated toxicity.Proceedings of the National Academy of Sciences of the United States of America · 2014
    Article
  8. Natural compounds may open new routes to treatment of amyloid diseases.Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics · 2013
    Review
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 2 countries.

Heath EcroydSchool of Chemistry and the Physics, University of Adelaide, Adelaide, South Australia. heath.ecroyd@adelaide.edu.au
Tomas Koudelka
David C Thorn
Danielle M Williams
Glyn Devlin
Peter Hoffmann
John A Carver
University of Adelaide · AUUniversity of Cambridge · GB

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Amyloid fibrils are aggregated and precipitated forms of protein in which the protein exists in highly ordered, long, unbranching threadlike formations that are stable and resistant to degradation by proteases. Fibril formation is an ordered process that typically involves the unfolding of a protein to partially folded states that subsequently interact and aggregate through a nucleation-dependent mechanism. Here we report on studies investigating the molecular basis of the inherent propensity of the milk protein, kappa-casein, to form amyloid fibrils. Using reduced and carboxymethylated kappa-casein (RCMkappa-CN), we show that fibril formation is accompanied by a characteristic increase in thioflavin T fluorescence intensity, solution turbidity, and beta-sheet content of the protein. However, the lag phase of RCMkappa-CN fibril formation is independent of protein concentration, and the rate of fibril formation does not increase upon the addition of seeds (preformed fibrils). Therefore, its mechanism of fibril formation differs from the archetypal nucleation-dependent aggregation mechanism. By digestion with trypsin or proteinase K and identification by mass spectrometry, we have determined that the region from Tyr(25) to Lys(86) is incorporated into the core of the fibrils. We suggest that this region, which is predicted to be aggregation-prone, accounts for the amyloidogenic nature of kappa-casein. Based on these data, we propose that fibril formation by RCMkappa-CN occurs through a novel mechanism whereby the rate-limiting step is the dissociation of an amyloidogenic precursor from an oligomeric state rather than the formation of stable nuclei, as has been described for most other fibril-forming systems.

Indexed as

Models, ChemicalAmyloidAnimalsBenzothiazolesCaseinsCattleEndopeptidase KMass SpectrometryNephelometry and TurbidimetrySpectrometry, FluorescenceThiazolesTrypsinAmyloidBenzothiazolesCaseinsEndopeptidase KThiazolesthioflavin TTrypsin

Identifiers

PMID18245081
PMCPMC2431022
OpenAlexW2133083191

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.